I will be in San Diego this April 17-20 for the BIO World Congress on Industrial Biotechnology to moderate and speak on the panel “Regulatory Growth and Commercial Development in Alternative Feedstocks and Algae“. My talk will provide an update on the ongoing U.S. federal government efforts to update and modernize the Coordinated Framework for Biotechnology Regulation. As always, I’ll be posting my slides online after the conference.
The BIO World Congress provides 3 days of robust programming, networking and partnering meetings via the BIO One-on-One Partnering™ System. According to BIO:
- 50% of attendees are international, coming from 30+ countries
- 30% of attendees are NEW industry professionals attending the event for the very first time
- 40% of attendees are C-Level or VP-level + hundreds of speakers.
There will be over 100 sessions featuring industry thought leaders in plenary sessions, breakout sessions across 8 dedicated tracks, GreenTech Investor sessions, an IP Symposium (new in 2016) and dedicated workshops. The conference affords an opportunity to catch up with colleagues, make new connections, and enjoy the networking opportunities at ten dedicated receptions, refreshment breaks, and other events throughout the week.
Here are some useful links:
- The Onsite Guide: Your all-access pass to the 2016 BIO World Congress: browse speakers, session descriptions, schedule, and more.
- Browse the full schedule: 100+ sessions and 200 speakers
- Schedule at a Glance or Sessions at a Glance
- Link to Registration
Email firstname.lastname@example.org if you have questions. Hope to see you in San Diego!
D. Glass Associates, Inc. is a consulting company specializing in government and regulatory affairs support for renewable fuels and industrial biotechnology. David Glass, Ph.D. is a veteran of over thirty years in the biotechnology industry, with expertise in industrial biotechnology regulatory affairs, U.S. and international renewable fuels regulation, patents, technology licensing, and market and technology assessments. More information on D. Glass Associates’ regulatory affairs consulting capabilities, and copies of some of Dr. Glass’s prior presentations on biofuels and biotechnology regulation, are available at www.slideshare.net/djglass99and at www.dglassassociates.com. The views expressed in this blog are those of Dr. Glass and D. Glass Associates and do not represent the views of any other organization with which Dr. Glass is affiliated. Please visit our other blog, Biofuel Policy Watch.